Logo image of AREIT.PA

ALTAREIT (AREIT.PA) Stock Fundamental Analysis

EPA:AREIT - Euronext Paris - Matif - FR0000039216 - Common Stock - Currency: EUR

487.3  0 (0%)

Fundamental Rating

2

AREIT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. AREIT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AREIT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AREIT had negative earnings in the past year.
AREIT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AREIT reported negative net income in multiple years.
AREIT had a positive operating cash flow in 4 of the past 5 years.
AREIT.PA Yearly Net Income VS EBIT VS OCF VS FCFAREIT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

AREIT has a Return On Assets of -1.61%. This is comparable to the rest of the industry: AREIT outperforms 40.63% of its industry peers.
Looking at the Return On Equity, with a value of -8.51%, AREIT is doing worse than 65.63% of the companies in the same industry.
With a Return On Invested Capital value of 0.76%, AREIT perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -1.61%
ROE -8.51%
ROIC 0.76%
ROA(3y)-2.85%
ROA(5y)-1.06%
ROE(3y)-14.56%
ROE(5y)-5.87%
ROIC(3y)N/A
ROIC(5y)N/A
AREIT.PA Yearly ROA, ROE, ROICAREIT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

AREIT's Operating Margin of 0.63% is in line compared to the rest of the industry. AREIT outperforms 46.88% of its industry peers.
AREIT's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 15.52%, AREIT is in line with its industry, outperforming 40.63% of the companies in the same industry.
In the last couple of years the Gross Margin of AREIT has declined.
Industry RankSector Rank
OM 0.63%
PM (TTM) N/A
GM 15.52%
OM growth 3Y-50.62%
OM growth 5Y-32.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.03%
GM growth 5Y-5.31%
AREIT.PA Yearly Profit, Operating, Gross MarginsAREIT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AREIT is destroying value.
AREIT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for AREIT remains at a similar level compared to 5 years ago.
Compared to 1 year ago, AREIT has a worse debt to assets ratio.
AREIT.PA Yearly Shares OutstandingAREIT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
AREIT.PA Yearly Total Debt VS Total AssetsAREIT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

AREIT has an Altman-Z score of 1.20. This is a bad value and indicates that AREIT is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of 1.20, AREIT is doing good in the industry, outperforming 70.31% of the companies in the same industry.
The Debt to FCF ratio of AREIT is 4.93, which is a neutral value as it means it would take AREIT, 4.93 years of fcf income to pay off all of its debts.
AREIT has a Debt to FCF ratio of 4.93. This is amongst the best in the industry. AREIT outperforms 90.63% of its industry peers.
A Debt/Equity ratio of 0.98 indicates that AREIT is somewhat dependend on debt financing.
The Debt to Equity ratio of AREIT (0.98) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 4.93
Altman-Z 1.2
ROIC/WACC0.13
WACC5.88%
AREIT.PA Yearly LT Debt VS Equity VS FCFAREIT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

AREIT has a Current Ratio of 1.17. This is a normal value and indicates that AREIT is financially healthy and should not expect problems in meeting its short term obligations.
AREIT has a Current ratio of 1.17. This is comparable to the rest of the industry: AREIT outperforms 50.00% of its industry peers.
AREIT has a Quick Ratio of 1.17. This is a bad value and indicates that AREIT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.80, AREIT is in line with its industry, outperforming 57.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.8
AREIT.PA Yearly Current Assets VS Current LiabilitesAREIT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 81.27% over the past year.
The Revenue has been growing slightly by 0.95% in the past year.
The Revenue has been decreasing by -3.00% on average over the past years.
EPS 1Y (TTM)81.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.97%
Revenue 1Y (TTM)0.95%
Revenue growth 3Y-4.16%
Revenue growth 5Y-3%
Sales Q2Q%6.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AREIT.PA Yearly Revenue VS EstimatesAREIT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AREIT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AREIT.PA Price Earnings VS Forward Price EarningsAREIT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

AREIT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AREIT is cheaper than 67.19% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AREIT indicates a rather cheap valuation: AREIT is cheaper than 89.06% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.75
EV/EBITDA 19.69
AREIT.PA Per share dataAREIT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AREIT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALTAREIT

EPA:AREIT (5/9/2025, 7:00:00 PM)

487.3

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)02-25 2025-02-25
Earnings (Next)07-28 2025-07-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners99.85%
Ins Owner ChangeN/A
Market Cap852.77M
Analysts78
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.34
P/FCF 3.75
P/OCF 3.33
P/B 1.19
P/tB 2.21
EV/EBITDA 19.69
EPS(TTM)-34.89
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)130
FCFY26.68%
OCF(TTM)146.4
OCFY30.04%
SpS1414.4
BVpS409.77
TBVpS220.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.61%
ROE -8.51%
ROCE 1.22%
ROIC 0.76%
ROICexc 1.34%
ROICexgc 2.2%
OM 0.63%
PM (TTM) N/A
GM 15.52%
FCFM 9.19%
ROA(3y)-2.85%
ROA(5y)-1.06%
ROE(3y)-14.56%
ROE(5y)-5.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-39.13%
ROICexcg growth 5Y-24.87%
ROICexc growth 3Y-44.01%
ROICexc growth 5Y-28.25%
OM growth 3Y-50.62%
OM growth 5Y-32.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.03%
GM growth 5Y-5.31%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 4.93
Debt/EBITDA 12.63
Cap/Depr 71.75%
Cap/Sales 1.16%
Interest Coverage 0.25
Cash Conversion 460.79%
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 0.8
Altman-Z 1.2
F-Score5
WACC5.88%
ROIC/WACC0.13
Cap/Depr(3y)26.41%
Cap/Depr(5y)37.36%
Cap/Sales(3y)0.42%
Cap/Sales(5y)0.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.95%
Revenue growth 3Y-4.16%
Revenue growth 5Y-3%
Sales Q2Q%6.64%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y104.75%
EBIT growth 3Y-52.68%
EBIT growth 5Y-34.13%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y103.67%
FCF growth 3Y76.04%
FCF growth 5Y6.06%
OCF growth 1Y127.53%
OCF growth 3Y70.6%
OCF growth 5Y7.85%